For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved

— Research monograph

GLOW Blend (BPC-157 · GHK-Cu · TB-500)

GLOWskin blend

A three-peptide repair + skin-signaling co-formulation in one vial.

Updated

Class
Merit co-formulation: BPC-157 + GHK-Cu + TB-500 (Thymosin Beta-4 fragment)
Half-life (research)
Component-dependent (see the individual BPC-157, GHK-Cu, and TB-500 records).
Origin
GLOW is a Merit-specific co-formulation rather than a single characterized molecule. Each component carries its own research record: BPC-157 (Sikiric laboratory, University of Zagreb, early 1990s), GHK-Cu (Pickart, 1973), and TB-500 / Thymosin Beta-4 (Goldstein, 1981).
Solubility
Water-soluble. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures.

What is GLOW Blend (BPC-157 · GHK-Cu · TB-500)?

GLOW combines three peptides that recur in tissue-repair and extracellular-matrix research: BPC-157, a stable gastric pentadecapeptide; GHK-Cu, a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied in collagen and remodeling contexts; and TB-500, a synthetic fragment of the actin-binding peptide Thymosin Beta-4.

Because GLOW is a co-formulation, it has no separate published literature of its own — the relevant research belongs to each component. Merit supplies it as a single research preparation for laboratory use only.

How does GLOW Blend (BPC-157 · GHK-Cu · TB-500) work?

Component-level: BPC-157 is studied for cytoprotective and angiogenic signaling; GHK-Cu for copper-dependent modulation of extracellular-matrix and remodeling genes; TB-500 for actin sequestration and cell-migration pathways. No combined mechanism is established for the blend.

Research applications

  • Tissue-repair pathway research (component-based)
  • Extracellular-matrix and collagen models
  • Angiogenesis and cell-migration studies
  • Comparative peptide co-formulation research

GLOW Blend (BPC-157 · GHK-Cu · TB-500) at Merit

Form & storage

GLOW Blend (BPC-157 · GHK-Cu · TB-500) ships as a sealed, lyophilized (freeze-dried) powder. Water-soluble. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures. Store sealed, light-protected, and follow your institution’s handling procedures for research materials.

Frequently asked questions

What is GLOW Blend (BPC-157 · GHK-Cu · TB-500)?

GLOW combines three peptides that recur in tissue-repair and extracellular-matrix research: BPC-157, a stable gastric pentadecapeptide; GHK-Cu, a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied in collagen and remodeling contexts; and TB-500, a synthetic fragment of the actin-binding peptide Thymosin Beta-4. Merit supplies it as a lyophilized research compound for research use only, not for human or veterinary use.

How does GLOW Blend (BPC-157 · GHK-Cu · TB-500) work?

Component-level: BPC-157 is studied for cytoprotective and angiogenic signaling; GHK-Cu for copper-dependent modulation of extracellular-matrix and remodeling genes; TB-500 for actin sequestration and cell-migration pathways. No combined mechanism is established for the blend. Mechanistic descriptions summarize published preclinical findings and are not clinical claims.

What is the half-life of GLOW Blend (BPC-157 · GHK-Cu · TB-500)?

Component-dependent (see the individual BPC-157, GHK-Cu, and TB-500 records). Values reflect preclinical or research-context reports, not clinical pharmacokinetics.

Is Merit GLOW Blend (BPC-157 · GHK-Cu · TB-500) for human use?

No. It is sold strictly for research use only: not for human or veterinary use, and not for diagnostic or therapeutic use.

Is GLOW Blend (BPC-157 · GHK-Cu · TB-500) FDA-approved?

None of its components (BPC-157, GHK-Cu, TB-500) is approved by the FDA for any use, and no FDA-approved product combines them. Supplied for research use only. Two components are named on the WADA 2026 Prohibited List: BPC-157 under S0 and TB-500 under S2.

How is each batch of GLOW Blend (BPC-157 · GHK-Cu · TB-500) tested?

Every Merit batch is tested by an independent laboratory for identity and HPLC purity before it is listed, and Merit identifies batches by date rather than by lot number. Current certificates: GLOW (BPC-157, GHK-Cu, TB-500) 70 mg, July 2026 batch, 99.81% purity (meritsciences.com/coa/COA-2026-OHUG9D).

Regulatory status checked October 22, 2026 against: committee vote report (Healio), FDA 503A categories list, FDA Category 2 list, WADA Prohibited List.

References

  1. Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Sikiric P, Seiwerth S, Rucman R, et al.. Current Pharmaceutical Design, 2011 · doi:10.2174/138161211796196954
  2. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Pickart L, Margolina A. Oxidative Medicine and Cellular Longevity, 2012 · doi:10.1155/2012/324832

For research use only. Not for human or veterinary use. Reference information summarized from published literature, not medical advice.